05/05/2026
OPINION | Ozempic, GLP1s and “weight-loss” drugs have become buzzwords across the internet and social media. Searches containing the hashtag “Ozempic” have garnered 70 million views on TikTok and Google queries with “weight loss” and “GLP1” reached their peak in May 2024 and March 2025, respectively.
But within the world of this so-called wonder drug, there lie serious questions that require answering. Mainly, what are they, where did this sudden, lucrative craze come from and what does it say about the rigid, white and oppressive beauty standards in American society?
Ozempic is classified as a GLP-1, which stands for glucagon-like peptide, a class of medications used predominantly for the treatment of type-2 diabetes and obesity. Although Ozempic was originally approved by the FDA in 2017 as a diabetes medication, users quickly discovered and began reporting on its positive effects for rapid weight loss.
Thus, its manufacturing company, Novo Nordisk, created a separate drug, Wegovy, containing the active ingredient to trigger weight loss, semaglutide, in 2021 and it became an approved treatment for obesity-caused heart disease in 2024.
According to a study done by Indiana University School of Medicine, within the four years of collected data (from 2017-2021), the number of Americans using Ozempic increased 40 times, with roughly 9 million citizens, or 2-3 percent of the population, now regularly using some form.
Although this number is large and somewhat frightening, considering science has yet to uncover the long-term side effects of persistent usage, it’s not altogether shocking considering the obsession many Americans have with weight and how deeply it’s tied to the country’s beauty standards.
🔗 Click the link in our bio to read more on how the recent boom in weight loss drugs is another step in a long history of body negativity.
✍🏽: Tara Ulich
📸: Cymphani Hargrave/The Hilltop